EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice.

Susanne Gahr* (First author), R Stoehr, E Geissinger, Joachim H. Ficker (Co-author), W M Brueckl (Co-author), A Gschwendtner, S Gattenloehner, F S Fuchs, C Schulz, R J Rieker, A Hartmann, P Ruemmele, W Dietmaier

*Corresponding author for this work

Research output: Contribution to journalOriginal Article (Journal)peer-review

106 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1821-1828
JournalBRITISH JOURNAL OF CANCER
Volume109
Issue number7
DOIs
Publication statusPublished - 2013

Keywords

  • CELL LUNG-CANCER
  • GROWTH-FACTOR-RECEPTOR
  • TRANSCRIPTION FACTOR-I
  • KRAS MUTATIONS
  • 1ST-LINE TREATMENT
  • CLINICAL-RESPONSE
  • TTF-1 EXPRESSION
  • GENE-MUTATIONS
  • NEVER-SMOKERS
  • OPEN-LABEL

Cite this